Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between Glycosylated Hemoglobin A1c (HbA1c) and Outcomes in the Critically Ill

NCT02822976 is registered in ClinicalTrials.gov with Roupen Hatzakorzian, MD as lead sponsor.

NCT NCT02822976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02822976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between Glycosylated Hemoglobin A1c (HbA1c) and Outcomes in the Critically Ill
Lead sponsor
Roupen Hatzakorzian, MD
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
June 30, 2016
Enrollment
2,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness